Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification

Stem Cells

Volumn 27, Issue 1, 2009, Pages 150-156

  Kan, Lixin ^a   Liu, Yijie ^a   McGuire, Tammy L ^a   Palila Berger, Diana M ^a   Awatramani, Rajeshwar B ^a   Dymecki, Susan M ^b   Kessler, John A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Fibrodysplasia ossificans progressiva; Heterotopic ossification; Macrophages; Nse BMP4

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HETEROTOPIC OSSIFICATION; MACROPHAGE; MOUSE; MUSCLE INJURY; NONHUMAN; OSSIFYING MYOSITIS; PATHOGENESIS; SKIN INJURY; STEM CELL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL LINEAGE; IMMUNE SYSTEM; INTEGRASES; MACROPHAGES; MICE; MODELS, BIOLOGICAL; MUSCLES; OSSIFICATION, HETEROTOPIC; PHOSPHOPYRUVATE HYDRATASE; SKIN; STEM CELLS;

ANIMALIA;

EID: 59849119987     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0576     Document Type: Article

References (43)

1. Vanden Bossche L, Vanderstraeten G. Heterotopic ossification: a review. J Rehabil Med 2005;37:129-136.
2. McCarthy EF, Sundaram M. Heterotopic ossification: a review. Skeletal Radiol 2005;34:609-619.
3. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006;65:1289-1299.
4. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002;43:346-353.
5. Kaplan FS, Glaser DL, Hebela N et al. Heterotopic ossification. J Am Acad Orthop Surg 2004;12:116-125.
6. Kitisin K, Saha T, Blake T et al. Tgf-Beta signaling in development. Sci STKE 2007:cm1.
7. Shore EM, Xu M, Feldman GJ et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-527.
8. Furuya H, Ikezoe K, Wang L et al. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 2008;146A:459-463.
9. Scarlett RF, Rocke DM, Kantanie S et al. Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 2004;275-279.
10. Kan L, Hu M, Gomes WA et al. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 2004;165:1107-1115.
11. Boubaker el Andalousi R, Daussin PA, Micallef JP et al. Changes in mass and performance in rabbit muscles after muscle damage with or without transplantation of primary satellite cells. Cell Transplant 2002;11:169-180.
12. Stoneman V, Braganza D, Figg N et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007;100:884-893.
13. Rickert RC, Roes J, Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 1997;25:1317-1318.
14. Hennet T, Hagen FK, Tabak LA et al. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci U S A 1995;92:12070-12074.
15. Clausen BE, Burkhardt C, Reith W et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999;8:265-277.
16. Tallquist MD, Weismann KE, Hellstrom M et al. Early myotome specification regulates PDGFA expression and axial skeleton development. Development 2000;127:5059-5070.
17. Dubois NC, Hofmann D, Kaloulis K et al. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis 2006;44:355-360.
18. Kan L, Jalali A, Zhao LR et al. Dual function of Sox1 in telencephalic progenitor cells. Dev Biol 2007;310:85-98.
19. Alves-Rosa F, Stanganelli C, Cabrera J et al. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 2000;96:2834-2840.
20. Wu G, Korsgren O, Zhang J et al. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic animals. Xenotransplantation 2000;7:214-220.
21. Zito MA, Koennecke LA, McAuliffe MJ et al. Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates striatal macrophage invasion and neurodegeneration following local endotoxin infusion in gerbils. Brain Res 2001;892:13-26.
22. Zeisberger SM, Odermatt B, Marty C et al. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006;95:272-281.
23. Van Rooijen N. The liposome-mediated macrophage 'suicide' technique. J Immunol Methods 1989;124:1-6.
24. Duffield JS, Forbes SJ, Constandinou CM. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
25. Mombaerts P, Iacomini J, Johnson RS et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992;68:869-877.
26. Hegyi L, Gannon FH, Glaser DL et al. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification? J Pathol 2003;201:141-148.
27. Gannon FH, Glaser D, Caron R et al. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 2001;32:842-848.
28. Rumi MN, Deol GS, Singapuri KP et al. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. J Orthop Res 2005;23:34-40.
29. Michelsson JE, Granroth G, Andersson LC. Myositis ossificans following forcible manipulation of the leg. A rabbit model for the study of heterotopic bone formation. J Bone Joint Surg Am 1980;62:811-815.
30. Lin L, Chen L, Wang H et al. Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. Biochem Biophys Res Commun 2006;349:564-572.
31. O'Connor JP. Animal models of heterotopic ossification. Clin Orthop Relat Res 1998;71-80.
32. Dabrowiecki S, Svanes K, Lekven J et al. Tissue reaction to polypropylene mesh: a study of oedema, blood flow, and inflammation in the abdominal wall. Eur Surg Res 1991;23:240-249.
33. Signorelli SS, Malaponte MG, Di Pino L et al. Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc 2000;22:311-316.
34. Liprandi A, Bartoli C, Figarella-Branger D. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol (Berl) 1999;97:642-648.
35. Popovich PG, Hickey WF. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 2001;60:676-685.
36. Honda Y, Anada T, Kamakura S et al. Elevated extracellular calcium stimulates secretion of bone morphogenetic protein 2 by a macrophage cell line. Biochem Biophys Res Commun 2006;345:1155-1160.
37. Takebe J, Champagne CM, Offenbacher S et al. Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A. 1 macrophage cell line. J Biomed Mater Res A 2003;64:207-216.
38. Champagne CM, Takebe J, Offenbacher S et al. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 2002;30:26-31.
39. Friedenstein A, Kuralesova AI. Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation 1971;12:99-108.
40. Diaz-Flores L, Gutierrez R, Lopez-Alonso A et al. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin Orthop Relat Res 1992;280-286.
41. Esenwein SA, Sell S, Herr G et al. Effects of single-dose versus fractionated irradiation on the suppression of heterotopic bone formation-an animal model-based follow-up study in rats. Arch Orthop Trauma Surg 2000;120:575-581.
42. Benetos IS, Mavrogenis AF, Themistocleous GS et al. Optimal treatment of fibrodysplasia ossificans progressiva with surgical excision of heterotopic bone, indomethacin, and irradiation. J Surg Orthop Adv 2006;15:99-104.
43. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-319.